Stocks Immunovant Receives Patent for Antibodies Against Autoimmune Diseases From Investing.comMarch 12, 2024 NEW YORK – Immunovant, Inc. (NASDAQ:), a clinical-stage immunology company, has been awarded a U.S.…
